On the recordApril 25, 2022
I have heard serious concerns that FDA is responding to some meeting requests with a 'written response only.'
Source
congress.govEditor's note · Context
Collins expresses concerns about FDA's limited engagement with drug sponsors.
Share & report
More from Susan Collins
Jan 10, 2026
a fiscally responsible move that will spur scientific research necessary to maintain U.S. competitiveness
Aug 29, 2025
Article I of the Constitution makes clear that Congress has the responsibility for the power of the purse.
Jul 8, 2025
My vote against this bill stems primarily from the harmful impact it will have on Medicaid, affecting low-income families and rural health care providers like our hospitals and nursing homes.
Other voices in this conversation
